TP53 and Alzheimer disease: As shown in Table 1, there were 13 out of 22 (59%) patients with SCC who were TP53 positive, while 23% (25 out of 107) and 36% (5 out of 14) of patients with AD and miscellaneous lung tumors were TP53 positive, respectively.